Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This spontaneous report was received from the patient''s mother via social media concerning her female daughter of unknown age. The patient''s concurrent conditions and medical history were not reported. On an unknown date, the patient was vaccinated with an unspecified dose of GARDASIL strength reported as: 0.5 ml, via intramuscularly route (lot, expiry date, dosage schedule, and anatomical location were not specified). Other suspect and concomitant medication were not reported. On an unknown date, the patient presented allergy and migraine. Also on an unknown date, patient experienced unspecified adverse event. The outcome of adverse event, migraine and hypersensitivity were unknown at the time of reporting. The relatedness between the events with GARDASIL were not reported. The unspecified adverse event was considered serious by the reporter due to disability caused. Follow up information has been received from the patient''s mother via social media on 03-OCT-2016, who reported that on an unspecified date, the patient also experienced strabismus in the left eye, cephalea and muscles cramps. The patient had been treated with biomedicine and it was observed a recovering in strabismus, cephalea and muscles cramps events. The reporter considered that strabismus, cephalea and muscles cramps were related to GARDASIL. The strabismus was considered serious by the reporter due to disability caused. Additional information is not expected as there were no contact details provided. Patient details, event information and narrative were updated.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166